hSMG-1 inhibitor 11j |
Katalog-Nr.GC61925 |
Der hSMG-1-Inhibitor 11j, ein Pyrimidinderivat, ist ein potenter und selektiver Inhibitor von hSMG-1 mit einem IC50-Wert von 0,11 nM. Der hSMG-1-Inhibitor 11j zeigt eine >455-fache SelektivitÄt fÜr hSMG-1 gegenÜber mTOR (IC50=50 nM), PI3Kα/γ (IC50=92/60 nM) und CDK1/CDK2 (IC50=32/7,1 μM). Der hSMG-1-Inhibitor 11j kann fÜr die Krebsforschung eingesetzt werden.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1402452-15-6
Sample solution is provided at 25 µL, 10mM.
hSMG-1 inhibitor 11j, a pyrimidine derivative, is a potent and selective inhibitor of hSMG-1, with an IC50 of 0.11 nM. hSMG-1 inhibitor 11j exhibits >455-fold selectivity for hSMG-1 over mTOR (IC50=50 nM), PI3Kα/γ (IC50=92/60 nM) and CDK1/CDK2 (IC50=32/7.1 µM). hSMG-1 inhibitor 11j can be used for the research of cancer[1].
hSMG-1 inhibitor 11j (0.3-3 µM; 6 h) significantly reduces UPF1 phosphorylation at 0.3 µM, and eliminates it at 1 µM in MDA 361 cells[1].hSMG-1 inhibitor 11j inhibits MDA468 cell proliferation, with an IC50 of 75 nM[1].
References:
[1]. Gopalsamy A, et, al. Identification of pyrimidine derivatives as hSMG-1 inhibitors. Bioorg Med Chem Lett. 2012 Nov 1;22(21):6636-41.
Average Rating: 5
(Based on Reviews and 28 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *